AFME.PA - AFFLUENT MEDICAL
€1.76 -0.02 (-1.12%)
Updated: 08:45 May 10, 2024 ESTNext Session's AI Forecast
94.42%
Avg. Accuracy (AI)
€1.55
Next Week's AI Forecast
100%
Trend's Accuracy (AI)
€1.67
Rank (0-100) |
Rank (0-100) |
Curr. Week | Curr. Month | Curr. Quarter | Next Quarter | Curr Year | 3.06 | -0.59 | 0.25 | 0.39 | 0.21 |
---|
CURRENT VOLATILITY RANK
Variation from the lowest to the highest value in a period.
Curr. Week | Curr. Month | Curr. Quarter | Next Quarter | Curr Year | 3.06 | 2.33 | 3.72 | 3.44 | 3.18 |
---|
STOCHASTIC METRIC
The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.
Curr. Week | Next Week | Curr. Month | Curr. Quarter | 100% | 100% | 46.51% | 65.82% |
---|
MOVING AVERAGE METRIC
5 Sessions | Change 5 Sessions | 20 Sessions | Change 20 Sessions | 50 Sessions | Change 50 Sessions | 200 Sessions | 1.68 | -1.75% | 1.71 | -4.47% | 1.79 | 14.74% | 1.56 |
---|
RSI METRIC
RS Hour | RSI Hour | RS Day | RSI Day | 0.5 | -1 | 1 | 33.33 |
---|
AFFLUENT MEDICAL Technical Analysis News
AFFLUENT MEDICAL
320, avenue Archimède
Les Pléiades III – Bâtiment B
Aix-en-Provence 13100
France
33 4 42 95 12 20
https://www.affluentmedical.com
Sectors: | Healthcare |
Industry: | Medical Devices |
F. Time Employees: | 52 |
Description
Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.
Corporate Governance
Affluent Medical SA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.